InvestorsHub Logo
icon url

doogdilinger

08/13/15 5:35 PM

#12827 RE: crimsonreign #12826

BOOOOOOOOOOOOOOM very nice find crimson>>>

The potential size of the commercial opportunity is huge, especially if the FDA blocks painkillers without anti-abuse features, or if the US Congress goes a step further by removing products without tamper protection from the market — a move some in the industry are lobbying for.

Ronny Gal, an analyst at Bernstein Research, is predicting an "intellectual property bonanza" for companies working in this field. He estimates that switching the 18-million US prescriptions that are filled with generic drugs to new abuse-deterrent alternatives would generate about $4.4bn for the industry each year.


icon url

AngeloFoca

08/17/15 7:58 PM

#12875 RE: crimsonreign #12826

@IPCIPharma: http://buff.ly/1NtpjSa

Hard shells and antagonists might foil the casual recreational user, but they can be easily circumvented by drug dealers with a basic grasp of chemistry.

Another problem is that the current technologies focus on preventing tampering with the pill — crushing, chewing, dissolving. But more than 90% of opioid abuse is oral. Most users just take more pills than they should.

***more than 90% of opioid abuse is oral. Most users just take more pills than they should.***

That's what will make IPCI's technology "best in class"... taking more than one pill just negates the effect.

It's only a matter of time